AbbVie's Skyrizi drug to treat psoriasis wins U.S. approval

24 april 2019 | Bron: Reuters Health

AbbVie Inc said on Tuesday that the U.S. Food and Drug Administration approved its Skyrizi drug as a treatment for plaque psoriasis at a time when its blockbuster psoriasis drug, Humira, faces patent pressures.

Lees verder op: Reuters Health